BioSpace News Archive

PhenomeX Inc., the functional cell biology company, announced the launch of Beacon Select™ optofluidic system with Opto® B Discovery workflows for antibody discovery.

Diligent Pharma Inc. announced today, the closing of an $8.27 Million Series A financing round led by FCA Venture Partners. Additional investors include PJC, and GenHenn Capital along with private investors who have held executive leadership roles in the pharmaceutical industry.

Vaso Corporation (“Vaso”) (OTCQB:VASO) today reported its operating results for the three months ended March 31, 2023.

ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, announces publication of an article in the peer-reviewed journal, Metabolism, which supports the mechanism of action of Cholesterol Efflux Mediator™ VAR 200 in development to treat kidney diseases.

Gracell Biotechnologies Inc. today announced that it will host a key opinion leader (KOL) webinar on May 22, 2023 at 9:00 am ET.

Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, today provided a corporate update and reported financial results for the first quarter of 2023 ended March 31, 2023.

Biofrontera Inc. (Nasdaq:BFRI) (the “Company”), a biopharmaceutical company specializing in the commercialization of dermatologic products, announces that the U.S. Patent and Trademark Office (USPTO) has granted a new patent to Biofrontera Bioscience GmbH related to a photodynamic therapy (PDT) protocol that is expected to be less painful but similarly effective to conventional PDT.

SOPHiA GENETICS, a cloud-native software company and the leader in data-driven medicine, celebrates with longstanding partner, Dasa, the largest integrated healthcare network in Brazil, as it reaches a milestone of 2,000 samples analyzed for HRD status.

Moss Genomics Inc. (CSE: MOSS) (“Moss” or the “Company”), a consumer genomics and gut microbiome company based in Vancouver, British Columbia, announces signing of a memorandum of understanding (“MOU”) with Proteic Bioscience Inc. (“Proteic”).

The Insight Partners published latest research report on “Global Artificial Intelligence in Healthcare Diagnosis Market Size Report, Share, Trends, Growth & Forecast to 2027 – COVID-19 Impact and Global Analysis – By Diagnostic Tool; Application; End User; and Service”, the global market is expected to reach USD 66,811.97 million by 2027 from USD 3,639.02 million in 2019.